A. G. Firth et al. / Tetrahedron Letters 47 (2006) 3529–3533
3533
10. Compound 6a and related derivatives need to be isolated
by solvent extraction and purified by laborious column
chromatography.
References and notes
1. (a) De Clercq, E. Biochem. Pharmacol. 1984, 33, 2159; (b)
Minakawa, N.; Kojima, N.; Sasaki, T.; Matsuda, A.
Nucleosides Nucleotides 1996, 15, 251; (c) De Clercq, E.;
Descamps, J.; De Somer, P.; Barr, P. J.; Jones, A. S.;
Walker, R. T. Proc. Natl. Acad. Sci. U.S.A. 1979, 76,
2947; (d) Manfredini, S.; Baraldi, P. G.; Bazzanini, R.;
Marangoni, M.; Simoni, D.; Balzarini, J.; De Clercq, E. J.
Med. Chem. 1995, 38, 199; (e) Hocek, M.; Holy, A.;
11. (a) Li, J. H.; Zhang, X. D.; Xie, Y. X. Eur. J. Org. Chem.
2005, 4256; (b) Anderson, K. W.; Buchwald, S. L. Angew.
Chem., Int. Ed. 2005, 44, 6173; (c) Lemhadri, M.; Doucet,
H.; Santelli, M. Tetrahedron 2005, 61, 9839; (d) Batchu, V.
R.; Subramanian, V.; Parasuraman, K.; Swamy, N. K.;
Kumar, S.; Pal, M. Tetrahedron 2005, 61, 9869; (e)
Shirakawa, E.; Kitabata, T.; Otsuka, H.; Tsuchimoto, T.
Tetrahedron 2005, 61, 9878; (f) Li, J. H.; Zhang, X. D.;
Xie, Y. X. Synthesis 2005, 804; (g) Mery, D.; Heuze, K.;
Astruc, D. Chem. Commun. 2003, 1934; Bohm, V. P. W.;
Herrmann, W. A. Eur. J. Org. Chem. 2000, 3679.
´
´
Votruba, I.; Dvorakova, H. J. Med. Chem. 2000, 43,
1817.
2. (a) Thoresen, L. H.; Jiao, G.-S.; Haaland, W. C.; Metzker,
M. L.; Burgess, K. Chem. Eur. J. 2003, 9, 4603; (b)
Caretta, A.; Cavaggioni, A.; Sorbi, R. T. Eur. J. Biochem.
1985, 153, 49; (c) Langer, P. R.; Waldrop, A. A.; Ward, D.
C. Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 6633; (d)
Shimkus, M.; Levy, J.; Herman, T. Proc. Natl. Acad. Sci.
U.S.A. 1985, 82, 2593; (e) Crisp, G. T.; Gore, J. Tetra-
hedron 1997, 53, 1523.
12. General procedure:
A solution of 8-bromoguanosine
(520 mg, 1.5 mmol, 1 equiv) in dry DMF (12 mL) was
added to the substituted phenylacetylene (1.8 mmol,
1.2 equiv) and dry triethylamine (0.63 mL, 4.5 mmol,
3 equiv) in a vacuum dried Schlenk tube. PdCl2(PPh3)2
(11 mg, 0.015 mmol, 1 mol %) and CuI (6 mg, 0.030 mmol,
2 mol %) were added and the reaction mixture was left to
stir at 110 ꢁC for 18 h, after which time it was allowed to
cool to 40 ꢁC and the DMF removed in vacuo to leave a
brown solid. The solid was transferred to a sintered glass
filter and was washed with boiling water (5 · 200 mL),
EtOAc (5 · 25 mL) and diethyl ether (2 · 25 mL) yielding
the product as a light cream solid (0.53 g, 91%). Repre-
sentative data for 8-(20-phenylethynyl)guanosine: Mp 234–
236 ꢁC (decomp.); mmax (DMSO solution)/cmꢀ1 1695
(CO), 3126 and 3328 (NH), 3421 (OH); dH (400 MHz;
DMSO-d6) 3.65 (1H, m), 3.88 (1H, m), 3.84 (1H, s), 4.19
(1H, s), 4.99 (2H, m), 5.15 (1H, br s), 5.50 (1H, d, J 6.4),
5.89 (1H, d, J 6.4), 6.62 (2H, s), 7.51 (3H, m), 7.64 (2H,
m), 10.90 (1H, s); dC (128 MHz; DMSO-d6) 61.9, 70.4,
70.8, 79.4, 85.6, 88.2, 92.6, 117.5, 120.4, 128.9, 129.3,
129.9, 131.5, 151.1, 153.9, 156.0; m/z (FAB) MH+ 384
(2.5%), 369, 354, 277, 185 (100%); HRMS (MH+):
384.1299 (calcd for C18H18N5O5 384.1307).
3. For leading references, see: (a) Collings, J. C.; Parsons, A.
`
C.; Porres, L.; Beeby, A.; Batsanov, A. S.; Howard, J. A.
K.; Lydon, D. P.; Low, P. J.; Fairlamb, I. J. S.; Marder, T.
B. Chem. Commun. 2005, 2666; (b) Nguyen, P.; Yuan, Z.;
Agocs, L.; Lesley, G.; Marder, T. B. Inorg. Chim. Acta
1994, 220, 289; (c) Nguyen, P.; Todd, S.; Van den
Biggelaar, D.; Taylor, N. J.; Marder, T. B.; Whittmann,
F.; Friend, R. H. Synlett 1994, 299; (d) Biswas, M.;
Nguyen, P.; Marder, T. B.; Khundkar, L. R. J. Phys.
Chem. A. 1997, 101, 1689; (e) Nguyen, P.; Lesley, G.;
Marder, T. B.; Ledoux, I.; Zyss, J. Chem. Mater. 1997, 9,
406; (f) Fasina, T. M.; Collings, J. C.; Lydon, D. P.;
Albesa-Jove, D.; Batsanov, A. S.; Howard, J. A. K.;
Nguyen, P.; Bruce, M.; Scott, A. J.; Clegg, W.; Watt, S.
W.; Viney, C.; Marder, T. B. J. Mater. Chem. 2004, 14,
2395.
4. Fairlamb, I. J. S. Tetrahedron 2005, 61, 9661.
5. (a) Agrofoglio, L. A.; Gillaizeau, I.; Saito, Y. Chem. Rev.
2003, 103, 1875; (b) Hocek, M. Eur. J. Org. Chem. 2003,
245; (c) Lakshman, M. K. Curr. Org. Synth. 2005, 2, 83.
6. Volpini, R.; Costanzi, S.; Lambertucci, C.; Vittori, S.;
Klotz, K.-N.; Lorenzen, A.; Cristalli, G. Bioorg. Med.
Chem. Lett. 2001, 11, 1931, It is worthy of note that an
unusual rearrangement was seen on cross-coupling 1-
phenylprop-2-yn-1-ol with 3 to give an enone, rather than
the expected alkynol.
13. The molecular ion for the cross-coupled product was
1
detected by FAB-MS, but shown to be impure by H and
13C NMR spectroscopy.
14. It is acknowledged that electron-poor terminal acetylenes
may favour ligation to Pd(0), thus removing active catalyst
from the catalytic cycle. For more insightful detail, see:
Amatore, C.; Bensalem, S.; Ghalem, S.; Jutand, A.;
Medjour, Y. Eur. J. Org. Chem. 2004, 366.
15. Fairlamb, I. J. S.; Ba¨uerlein, P. S.; Marrison, L. R.;
Dickinson, J. M. Chem. Commun. 2003, 632.
7. Flasche, W.; Cismas, C.; Herrmann, A.; Liebscher, J.
Synthesis 2004, 2335.
8. Western, E. C.; Shaughnessy, K. H. J. Org. Chem. 2005,
70, 6378.
16. Preliminary 31P NMR spectroscopic experiments indicate
that the excess Cu(I) reduces the amount of Pd(0) species
bound to 1 or 5, thereby releasing active catalyst into the
catalytic cycle. Complete details of these experiments will
be reported in a full paper.
´
9. Fairlamb, I. J. S.; Kapdi, A. R.; Lee, A. F.; Sanchez, G.;
´
´
´
´
Lopez, G.; Serrano, J. L.; Garcıa, L.; Perez, J.; Perez, E.
Dalton Trans. 2004, 3970.